Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
antiretroviral - search results
If you're not happy with the results, please do another search
HIV therapeutic targets: Basic virology to the discovery of antiretroviral drugs
Do we need new antiretroviral drugs to treat HIV infection, and if so, what are the promising targets? Dr Eric O. Freed, Director of the HIV Dynamics and Replication Program at the National Cancer Institute in Frederick, Maryland, discusses these questions.
NIH grants supports HIV care and climate change research
Researchers aim to uncover how extreme weather affects long-term HIV care outcomes and implications for addressing climate change impacts and other chronic health conditions.
Living with HIV: The prevalent pandemic which is no longer considered a pandemic
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explains that we need stronger efforts worldwide to end HIV transmission and improve the lives of those living with the disease.
Why have HIV outcomes improved with urban gardening?
An urban gardening program has received $3.4 million to reduce food insecurity in the Dominican Republic – and was also found to greatly improve HIV outcomes.
Eric O. Freed – Center for Cancer Research, National Cancer Institute
Dr. Eric O. Freed received his Ph.D. in 1990 from the University of Wisconsin-Madison
His Ph.D. work focused on the function of the murine leukemia virus and HIV envelope glycoproteins in membrane fusion and virus entry. He joined the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH...
PopART: Universal testing and treatment to stop HIV spread
Here, Professor of Epidemiology & International Health Richard Hayes explores and details the PopART study and other trials of Universal Testing and Treatment, a promising strategy to reduce HIV spread.
Taking complexity into account: Public health strategies adaption to the end of the decade
Dr Zisis Kozlakidis and Sandra Nanyonga discuss public health strategies, then and now, with a focus on the prevalence of STDs.
Could cutting-edge technology provide a potential HIV cure?
Scientists at AIDS 2022 describe how new technological insights into HIV latent cells could help HIV cure research.
New treatment for cryptococcal meningitis in people living with HIV
The WHO have new treatment guidelines for cryptococcal meningitis in people living with HIV - a single high dose of liposomal amphotericin B.
First case of woman cured from HIV, after dual stem-cell transplant
The first ever woman cured from HIV underwent a dual stem-cell transplant, which seems to have made her genetically resistant to HIV and put her cancer into remission.
Global COVID-19 responses could help to end HIV
Global COVID-19 responses could serve as a coordinated approach to end the HIV pandemic - bettering global immunisation to both viruses.
Third known case of HIV remission after stem cell transplant
After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months
FDA approves new long-lasting drug for HIV prevention
December saw monumental steps being taken in HIV prevention with the FDA approving their first approval of long-acting HIV prevention medication.
How can preferred HIV medication disproportionately impact women?
A new study on HIV medication treatment discovered persistent disparities between sex and age, potentially subjecting women to worse HIV treatment outcomes on the drug dolutegravir.
South Africa: An ongoing battle with HIV
With 7.5 million people living with HIV, how has climate change and COVID-19 affected the South African governments control over the AIDS crisis and which demographics have been hit the hardest?
People with HIV more likely to experience heart attacks
Research by the American Heart Association found that people with HIV are more likely to experience heart attacks - with "higher rates of sudden cardiac death".
Study finds 97% of women in Africa will work with HIV prevention methods
The REACH study found that 97% of women and girls in Uganda, South Africa and Zimbabwe are happy to work with HIV prevention methods - globally, half of all people living with HIV are women.
What is hyperpigmentation and how can it be prevented?
Dr Deborah Lee, Dr Fox Online Pharmacy, tells us all about hyperpigmentation including the different types, the causes and the treatment options.
Oxford University launch clinical trial for HIV vaccine
The team will have results to discuss in April, 2022 - they nurse the hope that this HIV vaccine could stop different geographical strains, after 40 years of no cure.
HIV patients are more likely to die from COVID-19
In a new study, researchers have found that individuals living with HIV and AIDS have an increased risk of death from COVID-19 infection.
